# LRRTM1

## Overview
LRRTM1 (leucine-rich repeat transmembrane neuronal 1) is a gene that encodes a synaptogenic cell adhesion protein predominantly expressed in the central nervous system. The LRRTM1 protein is characterized by leucine-rich repeat (LRR) domains, which facilitate its role in synaptic development and function by mediating protein-protein interactions. As a transmembrane protein, LRRTM1 is involved in the formation and maintenance of excitatory synapses, particularly through its interaction with presynaptic neurexins in a calcium-dependent manner. This interaction is crucial for synaptic specificity and plasticity, influencing cognitive processes such as memory and learning. Alterations in LRRTM1 expression or function have been associated with neuropsychiatric conditions, including schizophrenia, highlighting its clinical significance in maintaining synaptic integrity and brain asymmetry (Siddiqui2010LRRTMs; Takashima2011Impaired; Levchenko2014Sequencing).

## Structure
The LRRTM1 protein is characterized by leucine-rich repeat (LRR) domains, which are crucial for its role in synaptic development and function. These LRR domains facilitate protein-protein interactions and contribute to the protein's secondary structure, forming a horseshoe shape (Yamagata2019Structural). The extracellular domain (ECD) of LRRTM1 is composed of these LRR domains, which are essential for its interaction with presynaptic partners like neurexins. Specifically, LRRTM1 interacts transsynaptically with neurexins in a calcium-dependent manner, similar to LRRTM2, although the exact structural details of LRRTM1's interaction with neurexins are not fully detailed in the available context (Yamagata2019Structural).

The protein's structure is likely influenced by post-translational modifications, which can affect its activity and interactions, although specific modifications are not detailed in the context provided. The context does not provide detailed information on the primary, tertiary, or quaternary structures of LRRTM1, nor does it mention specific splice variant isoforms. The focus remains on the functional aspects of the LRR domains and their role in synaptic organization and plasticity (Dhume2022Distinct).

## Function
LRRTM1 is a synaptogenic cell adhesion molecule predominantly expressed in the central nervous system, including the hippocampus, cerebral cortex, and striatum. It plays a critical role in synapse development and function by promoting excitatory synapse formation and presynaptic differentiation. LRRTM1 interacts with presynaptic neurexins, particularly those lacking an insert at splice site S4, which is crucial for synaptic specificity (karimi2014assessing). The protein is active in the postsynaptic membrane, where it influences synaptic plasticity and neuronal connectivity, essential for cognitive processes (Takashima2011Impaired).

In the hippocampus, LRRTM1 is vital for long-term potentiation (LTP) at CA3-CA1 synapses, a process linked to long-term contextual memory. The deletion of LRRTM1 results in impaired LTP and memory deficits, highlighting its role in synaptic plasticity (Dhume2022Distinct). In the prefrontal cortex, LRRTM1 promotes AMPA receptor-mediated excitatory transmission and synaptic plasticity, binding presynaptic Neurexins and contributing to synapse organization and cognitive functions (de2023Concerted). The absence of LRRTM1 leads to altered synaptic density and cognitive deficits, underscoring its importance in maintaining synaptic structure and function (Takashima2011Impaired).

## Clinical Significance
Mutations and alterations in the expression of the LRRTM1 gene have been associated with several neuropsychiatric conditions, most notably schizophrenia. LRRTM1 is implicated in maintaining synaptic integrity, and its deletion in mice leads to cognitive impairments and altered hippocampal synapse morphology, which are relevant to schizophrenia (Takashima2011Impaired). The gene is also linked to brain asymmetry, which is a characteristic often disrupted in schizophrenia, suggesting that LRRTM1 may play a role in the condition's pathogenesis (Levchenko2014Sequencing).

LRRTM1 is maternally suppressed and paternally linked to handedness and schizophrenia, indicating a potential genetic mechanism underlying these associations (karimi2014assessing). In knockout mice, the absence of LRRTM1 results in reduced hippocampal volume and synaptic density, paralleling observations in schizophrenia patients (karimi2014assessing). Behavioral abnormalities in these mice, such as impaired cognitive function and social discrimination deficits, further support the gene's involvement in schizophrenia (Takashima2011Impaired).

The potential therapeutic implications of targeting LRRTM1-related pathways are highlighted by the observed effects of pharmacological agents like fluoxetine, which can mitigate some behavioral deficits in LRRTM1 knockout mice (Takashima2011Impaired).

## Interactions
LRRTM1 interacts with neurexins, specifically binding to neurexin variants that lack an insert at splice site 4 (−S4). This interaction is crucial for synaptic organization and is calcium-dependent, similar to the binding mechanism of neuroligins. LRRTM1 and LRRTM2 share a similar binding code, allowing them to bind to all α and β −S4 neurexin variants, but not to those with the splice site 4 insert (+S4) (Siddiqui2010LRRTMs; Yamagata2018Structural). The binding of LRRTM1 to neurexins is mutually exclusive with neuroligin-1, indicating competitive interactions at overlapping binding sites on neurexin-1β (Siddiqui2010LRRTMs).

LRRTM1 also plays a role in postsynaptic differentiation by recruiting proteins such as PSD-95 to dendrite contacts, which is essential for glutamatergic synapse development (Siddiqui2010LRRTMs). The C-terminal PDZ domain-binding motif of LRRTM1 is critical for its interaction with PSD-95, which acts as a scaffold protein in the postsynaptic membrane (Yamagata2018Structural). These interactions highlight the role of LRRTM1 in synaptic plasticity and neural circuit assembly. There is no mention of LRRTM1 interacting with nucleic acids in the provided context.


## References


[1. (Yamagata2019Structural) Atsushi Yamagata and Shuya Fukai. Structural insights into leucine-rich repeat-containing synaptic cleft molecules. Current Opinion in Structural Biology, 54:68–77, February 2019. URL: http://dx.doi.org/10.1016/j.sbi.2019.01.001, doi:10.1016/j.sbi.2019.01.001. This article has 6 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.sbi.2019.01.001)

[2. (Dhume2022Distinct) Shreya H Dhume, Steven A Connor, Fergil Mills, Parisa Karimi Tari, Sarah HM Au-Yeung, Benjamin Karimi, Shinichiro Oku, Reiko T Roppongi, Hiroshi Kawabe, Shernaz X Bamji, Yu Tian Wang, Nils Brose, Michael F Jackson, Ann Marie Craig, and Tabrez J Siddiqui. Distinct but overlapping roles of lrrtm1 and lrrtm2 in developing and mature hippocampal circuits. eLife, June 2022. URL: http://dx.doi.org/10.7554/elife.64742, doi:10.7554/elife.64742. This article has 8 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.7554/elife.64742)

[3. (Siddiqui2010LRRTMs) Tabrez J. Siddiqui, Raika Pancaroglu, Yunhee Kang, Amanda Rooyakkers, and Ann Marie Craig. Lrrtms and neuroligins bind neurexins with a differential code to cooperate in glutamate synapse development. The Journal of Neuroscience, 30(22):7495–7506, June 2010. URL: http://dx.doi.org/10.1523/JNEUROSCI.0470-10.2010, doi:10.1523/jneurosci.0470-10.2010. This article has 317 citations.](https://doi.org/10.1523/JNEUROSCI.0470-10.2010)

[4. (Levchenko2014Sequencing) Anastasia Levchenko, Stepan Davtian, Natalia Petrova, and Yegor Malashichev. Sequencing of five left–right cerebral asymmetry genes in a cohort of schizophrenia and schizotypal disorder patients from russia. Psychiatric Genetics, 24(2):75–80, April 2014. URL: http://dx.doi.org/10.1097/ypg.0000000000000021, doi:10.1097/ypg.0000000000000021. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.1097/ypg.0000000000000021)

[5. (de2023Concerted) Karen Perez de Arce, Adema Ribic, Dhrubajyoti Chowdhury, Katherine Watters, Garth J. Thompson, Basavaraju G. Sanganahalli, Elizabeth T. C. Lippard, Astrid Rohlmann, Stephen M. Strittmatter, Markus Missler, Fahmeed Hyder, and Thomas Biederer. Concerted roles of lrrtm1 and syncam 1 in organizing prefrontal cortex synapses and cognitive functions. Nature Communications, January 2023. URL: http://dx.doi.org/10.1038/s41467-023-36042-w, doi:10.1038/s41467-023-36042-w. This article has 12 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-023-36042-w)

[6. (Yamagata2018Structural) Atsushi Yamagata, Sakurako Goto-Ito, Yusuke Sato, Tomoko Shiroshima, Asami Maeda, Masahiko Watanabe, Takashi Saitoh, Katsumi Maenaka, Tohru Terada, Tomoyuki Yoshida, Takeshi Uemura, and Shuya Fukai. Structural insights into modulation and selectivity of transsynaptic neurexin–lrrtm interaction. Nature Communications, September 2018. URL: http://dx.doi.org/10.1038/s41467-018-06333-8, doi:10.1038/s41467-018-06333-8. This article has 30 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-018-06333-8)

7. (karimi2014assessing) Parisa Karimi Tari. Assessing the role of LRRTMs in synapse development and function. PhD thesis, University of British Columbia, 2014. This article has 0 citations.

[8. (Takashima2011Impaired) Noriko Takashima, Yuri S. Odaka, Kazuto Sakoori, Takumi Akagi, Tsutomu Hashikawa, Naoko Morimura, Kazuyuki Yamada, and Jun Aruga. Impaired cognitive function and altered hippocampal synapse morphology in mice lacking lrrtm1, a gene associated with schizophrenia. PLoS ONE, 6(7):e22716, July 2011. URL: http://dx.doi.org/10.1371/journal.pone.0022716, doi:10.1371/journal.pone.0022716. This article has 43 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0022716)